# Trial in Low Grade Glioma Patients: Wait or Treat

> **NCT03763422** · PHASE3 · TERMINATED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 19 (actual)

## Conditions studied

- Low-grade Glioma
- Temozolomide
- Phase III
- Wait or Treat

## Interventions

- **DRUG:** Temozolomide
- **RADIATION:** Radiotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT03763422
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-16
- **Primary completion:** 2021-12-29
- **Final completion:** 2021-12-29
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Poorly recruiting
- **Last updated:** 2022-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03763422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03763422, "Trial in Low Grade Glioma Patients: Wait or Treat". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03763422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*